PP_1170x120_10-25-21

0.05%

Akorn gets FDA nod for betamethasone dipropionate lotion USP

Akorn gets FDA nod for betamethasone dipropionate lotion USP

LAKE FOREST, Ill. — Akorn, a leading specialty pharmaceutical company, Monday announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for betamethasone dipropionate lotion USP (Augmented), 0.05%. The product is manufactured at Akorn’s Amityville, N.Y. manufacturing facility.According to IQVIA, U.S. sales of betamethasone dipropionate

Glenmark receives ANDA approval for clobetasol propionate foam

Glenmark receives ANDA approval for clobetasol propionate foam

MUMBAI — Glenmark  Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for clobetasol propionate foam, 0.05% (Emulsion Formulation), a generic version of Olux 1-E Foam, 0.05%, from Mylan. According to IQVIATM sales data for the 12 month period ending July 2019, the Olux-E Foam, 0.05% market achieved

Adheris Health